新型化合物作为5-HT2A激动剂用于治疗精神疾病或中枢神经系统疾病
Ram W Sabnis1, Anika R Sabnis2
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
介绍了激活血清素5-HT2A受体的新型化合物. 这些化合物为精神疾病和中枢神经系统疾病提供了潜在的新疗法.
科学领域:
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- 胺5-HT2A受体与各种中枢神经系统 (CNS) 功能和疾病有关.
- 开发5-HT2A受体的选择性激动剂是神经精神病学药物发现的一个关键领域.
更多相关视频
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
CNS Stimulants: Psychedelic Agents
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Antipsychotic Drugs: Typical and Atypical Agents
Antidepressant Drugs: Overview
